Clinical Trials on Locally Advanced or Metastatic NSCLC
Total 2395 results
-
AstraZenecaTerminatedSubjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GCFinland
-
Gilead SciencesRecruitingStage IV Breast Cancer | Locally Advanced or Unresectable Metastatic Breast CancerTaiwan, Korea, Republic of, Greece, Spain, United States, Israel, France, Japan, Belgium, Poland, China, Singapore, Australia, Hungary, Czechia, Italy, South Africa, Hong Kong, Chile, Brazil, Argentina, Austria, Canada, Germany, Portugal, United Kingdom
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.RecruitingLocally Advanced or Metastatic Epithelial TumorChina
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, Peru and more
-
AstraZenecaTerminatedInoperable Locally Advanced or Metastatic Biliary Tract CancerJapan
-
Shanghai JMT-Bio Inc.Active, not recruitingLocal Advanced or Metastatic NSCLC | Harboring EGFR Common MutationChina
-
Mt. Sinai Medical Center, MiamiAmgenCompletedUnresectable Locally Advanced NSCLCUnited States
-
Coherus Biosciences, Inc.Not yet recruitingAdvanced or Metastatic Solid Tumors
-
Hanmi Pharmaceutical Company LimitedRecruitingAdvanced or Metastatic Solid TumorsKorea, Republic of, United States
-
Zhejiang UniversityNot yet recruitingUnresectable or Metastatic Advanced Solid Tumors
-
Bio-Thera SolutionsRecruitingAdvanced or Metastatic Solid TumorsChina
-
Chinese PLA General HospitalUTC Therapeutics Inc.RecruitingAdvanced or Metastatic Solid TumorsChina
-
Minghui Pharmaceutical Pty LtdNot yet recruitingAdvanced or Metastatic Solid TumorsAustralia
-
Hanmi Pharmaceutical Company LimitedRecruitingAdvanced or Metastatic Solid TumorsKorea, Republic of, Australia
-
Tallac TherapeuticsRecruitingAdvanced or Metastatic Solid TumorsUnited States, Australia
-
DynamiCure BiotechnologyTerminatedAdvanced or Metastatic Solid TumorsUnited States
-
Erasca, Inc.Active, not recruitingAdvanced or Metastatic Solid TumorsUnited States
-
Zai Lab (Shanghai) Co., Ltd.Mirati Therapeutics Inc.Active, not recruitingAdvanced or Metastatic Solid TumorChina
-
AkesoActive, not recruitingAdvanced or Metastatic Solid TumorsAustralia
-
BayerCompletedAdvanced or Metastatic Solid TumorUnited States, Spain, Korea, Republic of, Belgium, Singapore, Germany
-
3D Medicines (Sichuan) Co., Ltd.CompletedAdvanced or Metastatic Solid TumorsJapan
-
Synta Pharmaceuticals Corp.CompletedAdvanced or Metastatic Solid TumorsUnited States
-
Hefei TG ImmunoPharma Co., Ltd.RecruitingAdvanced or Metastatic Solid TumorsChina
-
Kangabio AUSTRALIA LTD PTYNot yet recruitingAdvanced or Metastatic Solid TumorsAustralia
-
Akesobio Australia Pty LtdRecruitingAdvanced or Metastatic Solid TumoursAustralia
-
Shanghai Miracogen Inc.RecruitingAdvanced or Metastatic Solid TumorsUnited States, China
-
Shanghai Junshi Bioscience Co., Ltd.TerminatedAdvanced or Metastatic Solid TumorsChina
-
Mirati Therapeutics Inc.Enrolling by invitationAdvanced or Metastatic Solid MalignanciesUnited States
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Amsterdam UMC, location VUmcTerminatedAdvanced or Metastatic Solid MalignancyNetherlands
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
Nykode Therapeutics ASANektar Therapeutics; Vaccibody ASCompletedLocally Advanced or Metastatic Solid TumoursGermany
-
DynamiCure BiotechnologyRecruitingAdvanced or Metastatic Solid TumorsUnited States, Australia
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingAdvanced or Metastatic Solid TumorsChina
-
Beijing Mabworks Biotech Co., Ltd.RecruitingAdvanced or Metastatic Solid TumorChina
-
Shanghai Henlius BiotechActive, not recruitingAdvanced or Metastatic Solid TumorsAustralia
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingAdvanced or Metastatic Solid TumorsUnited States, China, Croatia, Japan, Latvia, Poland, Brazil, Lithuania, Switzerland
-
Ono Pharmaceutical Co. LtdActive, not recruitingAdvanced or Metastatic Solid TumorsJapan
-
Bristol-Myers SquibbActive, not recruitingAdvanced or Metastatic Solid TumorsUnited States, Germany, Spain, United Kingdom, Italy, Canada, Denmark, Finland
-
Ono Pharmaceutical Co. LtdCompletedAdvanced or Metastatic Solid TumorsJapan
-
Pierre Fabre MedicamentActive, not recruitingAdvanced or Metastatic Solid TumorsFrance, Spain
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedAdvanced or Metastatic Solid TumorsChina
-
Shijiazhuang Yiling Pharmaceutical Co. LtdTigermed Consulting Co., LtdUnknownAdvanced or Metastatic Solid TumoursChina
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedAdvanced or Metastatic Solid TumorsFrance
-
Aptose Biosciences Inc.CompletedAdvanced or Metastatic Solid TumoursUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant Neoplasm | Metastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Locally Advanced Malignant NeoplasmUnited States
-
Tyligand Bioscience (Shanghai) LimitedRecruitingHas a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or LymphomaChina
-
M.D. Anderson Cancer CenterWithdrawnLocally Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Bone
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar TherapeuticsRecruitingLocally Advanced or Metastatic Urothelial CarcinomaKorea, Republic of, United States, Taiwan, Australia, United Kingdom, France, Greece, Italy, Belgium, Spain, Canada, Denmark, Germany